These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36326418)

  • 41. Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer.
    Ji D; Song C; Li Y; Xia J; Wu Y; Jia J; Cui X; Yu S; Gu J
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33106387
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paving the Path for Immune Enhancing Nutrition in Colon Cancer: Modulation of Tumor Microenvironment and Optimization of Outcomes and Costs.
    Ambrosio MR; Spagnoli L; Perotti B; Petrelli F; Caini S; Saieva C; Usai S; Bianchini M; Cavazzana A; Arganini M; Amorosi A
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer.
    Yasuda K; Nirei T; Sunami E; Nagawa H; Kitayama J
    Radiat Oncol; 2011 May; 6():49. PubMed ID: 21575175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 53BP1 expression and immunoscore are associated with the efficacy of neoadjuvant chemoradiotherapy for rectal cancer.
    Huang A; Xiao Y; Peng C; Liu T; Lin Z; Yang Q; Zhang T; Liu J; Ma H
    Strahlenther Onkol; 2020 May; 196(5):465-473. PubMed ID: 31828392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.
    Rao N; Qiu J; Wu J; Zeng H; Su F; Qiu K; Wu J; Yao H
    Chemotherapy; 2017; 62(4):246-255. PubMed ID: 28472798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infiltration of CD4, CD8, CD56, and Fox-P3-positive lymphocytes in breast carcinoma tissue after neoadjuvant chemotherapy with or without trastuzumab.
    Itoi N; Umeda T; Ishida M; Murata S; Mori T; Kawai Y; Tomida K; Shimizu T; Kushima R; Tani M
    Breast Dis; 2019; 38(2):57-65. PubMed ID: 31006655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1
    Liang H; Li H; Xie Z; Jin T; Chen Y; Lv Z; Tan X; Li J; Han G; He W; Qiu N; Jiang M; Zhou J; Xia H; Zhan Y; Cui L; Guo W; Huang J; Zhang X; Wu YL
    Thorac Cancer; 2020 Oct; 11(10):2941-2954. PubMed ID: 32894006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunonutrition in ovarian cancer: clinical and immunological impact?
    Ferrero A; Vassallo D; Geuna M; Fuso L; Villa M; Badellino E; Barboni M; Coata P; Santoro N; Delgado Bolton RC; Biglia N
    J Gynecol Oncol; 2022 Nov; 33(6):e77. PubMed ID: 36047379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation between tumor microenvironment-associated factors and the efficacy and prognosis of neoadjuvant therapy for rectal cancer.
    Zhang S; Bai W; Tong X; Bu P; Xu J; Xi Y
    Oncol Lett; 2019 Jan; 17(1):1062-1070. PubMed ID: 30655866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of enteral immunonutrition in patients with gastric carcinoma undergoing major surgery.
    Chen DW; Wei Fei Z; Zhang YC; Ou JM; Xu J
    Asian J Surg; 2005 Apr; 28(2):121-4. PubMed ID: 15851366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer.
    Teng F; Mu D; Meng X; Kong L; Zhu H; Liu S; Zhang J; Yu J
    Am J Cancer Res; 2015; 5(6):2064-74. PubMed ID: 26269765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic value of combining the CD8 + lymphocyte density and the circulating lymphocyte ratio in circumferential resection margin biopsy in rectal cancer.
    Wu B; Zhao S; Sheng Y; Ren L; Song G
    Medicine (Baltimore); 2018 Aug; 97(34):e11972. PubMed ID: 30142826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunonutrition before esophagectomy: Impact on immune surveillance mechanisms.
    Scarpa M; Kotsafti A; Fassan M; Scarpa M; Cavallin F; Nardi T; Pinto E; Alfieri R; Cagol M; Agostini M; Rugge M; Castagliuolo I; Castoro C
    Tumour Biol; 2017 Oct; 39(10):1010428317728683. PubMed ID: 29022493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer.
    Abdul Sater H; Marté JL; Donahue RN; Walter-Rodriguez B; Heery CR; Steinberg SM; Cordes LM; Chun G; Karzai F; Bilusic M; Harmon SA; Turkbey IB; Choyke PL; Schlom J; Dahut WL; Madan RA; Pinto PA; Gulley JL
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32269146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.
    Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z
    Digestion; 2012; 86(4):329-37. PubMed ID: 23207161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of neoadjuvant chemoradiotherapy on perioperative immune function of patients with locally advanced esophageal cancer.
    Tan JT; Yang Y; Mao NQ; Liu DS; Huang DM; Pan H; Xie T; Pan Q; Yang L; Zhong JH; Zuo CT
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27766708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
    Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
    [No Abstract]   [Full Text] [Related]  

  • 58. [Application of endoscopic tattooing with carbon nanoparticlet in the treatment for advanced colorectal cancer].
    Wang R; Zhan HL; Li DZ; Li HT; Yu L; Wang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):56-64. PubMed ID: 31958932
    [No Abstract]   [Full Text] [Related]  

  • 59. Systemic Inflammatory Markers Combined with Tumor-Infiltrating Lymphocyte Density for the Improved Prediction of Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
    Sawada R; Akiyoshi T; Kitagawa Y; Hiyoshi Y; Mukai T; Nagasaki T; Yamaguchi T; Konishi T; Yamamoto N; Ueno M; Fukunaga Y
    Ann Surg Oncol; 2021 Oct; 28(11):6189-6198. PubMed ID: 33876358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy).
    Cao Y; Han D; Yang S; Shi Y; Zhao S; Jin Q; Li J; Li C; Zhang Y; Shen W; He J; Wang M; Ji G; Li Z; He Y; Chen Q; Wei W; Chen C; Gong X; Wang J; Tan L; Wang H; Li H
    BMC Cancer; 2022 Jun; 22(1):650. PubMed ID: 35698100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.